Last 12 months
Inside the activity.
1 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 09, 2022 Filed Nov 14, 2022 17:59 UTC |
Nazareth Annette L.Director
|
GrantStock Option (Right to Buy) · Derivative | 2,730 | $0.00 Strike: $133.74 | $0.00 |
DisclosureSEC source: 0001225208-22-011622 · doc4.xml · derivative · entry 2 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,730 Underlying: Common Stock · 2,730 shares Expires 2032-11-09 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| November 09, 2022 Filed Nov 14, 2022 17:59 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 627 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-011622 · doc4.xml · nonDerivative · entry 1 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,859 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| November 09, 2022 Filed Nov 14, 2022 17:56 UTC |
Zavery AmitDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,730 | $0.00 Strike: $133.74 | $0.00 |
DisclosureSEC source: 0001225208-22-011624 · doc4.xml · derivative · entry 2 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,730 Underlying: Common Stock · 2,730 shares Expires 2032-11-09 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| November 09, 2022 Filed Nov 14, 2022 17:56 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 627 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-011624 · doc4.xml · nonDerivative · entry 1 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,841 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| November 09, 2022 Filed Nov 14, 2022 17:56 UTC |
Carter Pamela LDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,730 | $0.00 Strike: $133.74 | $0.00 |
DisclosureSEC source: 0001225208-22-011617 · doc4.xml · derivative · entry 2 Carter Pamela L · CIK 0001396958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,730 Underlying: Common Stock · 2,730 shares Expires 2032-11-09 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| November 09, 2022 Filed Nov 14, 2022 17:56 UTC |
Carter Pamela LDirector
|
GrantCommon Stock | 627 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-011617 · doc4.xml · nonDerivative · entry 1 Carter Pamela L · CIK 0001396958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,982 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| November 09, 2022 Filed Nov 14, 2022 17:55 UTC |
Markus Maura A.Director
|
GrantStock Option (Right to Buy) · Derivative | 2,730 | $0.00 Strike: $133.74 | $0.00 |
DisclosureSEC source: 0001225208-22-011621 · doc4.xml · derivative · entry 2 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,730 Underlying: Common Stock · 2,730 shares Expires 2032-11-09 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| November 09, 2022 Filed Nov 14, 2022 17:55 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 627 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-011621 · doc4.xml · nonDerivative · entry 1 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,378.102 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 16:39 UTC |
Duelks Robert NDirector
|
GrantCommon Stock | 78 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-010883 · doc4.xml · nonDerivative · entry 1 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,117 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 12:40 UTC |
PERNA THOMAS JDirector
|
GrantCommon Stock | 78 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-010888 · doc4.xml · nonDerivative · entry 1 PERNA THOMAS J · CIK 0001209487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,394 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 16:39 UTC |
FLOWERS MELVIN LDirector
|
GrantCommon Stock | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-010884 · doc4.xml · nonDerivative · entry 1 FLOWERS MELVIN L · CIK 0001196490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 491 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 16:39 UTC |
keller brettDirector
|
GrantCommon Stock | 8 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-010885 · doc4.xml · nonDerivative · entry 2 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,627 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 16:39 UTC |
keller brettDirector
|
GrantCommon Stock | 28 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-010885 · doc4.xml · nonDerivative · entry 1 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,619 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 12:39 UTC |
BRUN LESLIE ADirector
|
GrantCommon Stock | 113 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-010881 · doc4.xml · nonDerivative · entry 1 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,850 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 16:40 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-010889 · doc4.xml · nonDerivative · entry 2 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,214 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 16:40 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 10 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-010889 · doc4.xml · nonDerivative · entry 1 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,212 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 16:40 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-010887 · doc4.xml · nonDerivative · entry 2 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,232 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 16:40 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-010887 · doc4.xml · nonDerivative · entry 1 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,230 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 16:39 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 13 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-010886 · doc4.xml · nonDerivative · entry 2 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,751.102 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 16:39 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 51 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-010886 · doc4.xml · nonDerivative · entry 1 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,738.102 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 16:39 UTC |
Carter Pamela LDirector
|
GrantCommon Stock | 14 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-010882 · doc4.xml · nonDerivative · entry 1 Carter Pamela L · CIK 0001396958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,355 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| October 05, 2022 Filed Aug 17, 2023 22:55 UTC Amendment |
Zavery AmitDirector
|
GrantCommon Stock | 7 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-008335 · doc4a.xml · nonDerivative · entry 1 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,224 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| October 01, 2022 Filed Oct 4, 2022 19:43 UTC |
Stingi Richard JohnCorporate VP and CHRO
|
GrantRestricted Stock Unit · Derivative | 1,511 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-010657 · doc4.xml · derivative · entry 1 Stingi Richard John · CIK 0001846577 · Corporate VP and CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,511 Underlying: Common Stock · 1,511 shares Expires not disclosed F1 · derivative.exercise_price: Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan representing a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into Broadridge common stock on April 1, 2025. F1 · shares: Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan representing a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into Broadridge common stock on April 1, 2025. F1 · derivative.exercise_date: Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan representing a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into Broadridge common stock on April 1, 2025. F1 · derivative.expiration_date: Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan representing a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into Broadridge common stock on April 1, 2025. Read SEC document |
| October 01, 2022 Filed Oct 4, 2022 19:43 UTC |
KALENKA ROBERT FCorporate Vice President
|
GrantRestricted Stock Unit · Derivative | 1,511 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-010656 · doc4.xml · derivative · entry 1 KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,511 Underlying: Common Stock · 1,511 shares Expires not disclosed F1 · derivative.exercise_price: Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan representing a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into Broadridge common stock on April 1, 2025. F1 · shares: Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan representing a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into Broadridge common stock on April 1, 2025. F1 · derivative.exercise_date: Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan representing a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into Broadridge common stock on April 1, 2025. F1 · derivative.expiration_date: Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan representing a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into Broadridge common stock on April 1, 2025. Read SEC document |
| September 28, 2022 Filed Sep 30, 2022 15:09 UTC |
keller brettDirector
|
GrantCommon Stock | 170 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-010483 · doc4.xml · nonDerivative · entry 1 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,591 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| September 28, 2022 Filed Sep 30, 2022 15:09 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 155 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-010486 · doc4.xml · nonDerivative · entry 1 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,202 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| September 28, 2022 Filed Sep 30, 2022 15:09 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 170 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-010485 · doc4.xml · nonDerivative · entry 1 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,228 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| September 28, 2022 Filed Sep 30, 2022 15:09 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 192 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-010484 · doc4.xml · nonDerivative · entry 1 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,687.102 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| August 26, 2022 Filed Aug 26, 2022 19:39 UTC |
DALY RICHARD JDirector · Executive Chairman
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 35,817 | $93.88 Strike: $93.88 | $3,362,499.96 |
DisclosureSEC source: 0001225208-22-009814 · doc4.xml · derivative · entry 11 DALY RICHARD J · CIK 0001198860 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,817 shares Expires 2028-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 26, 2022 Filed Aug 26, 2022 19:39 UTC |
DALY RICHARD JDirector · Executive Chairman
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 36,780 | $98.31 Strike: $98.31 | $3,615,841.80 |
DisclosureSEC source: 0001225208-22-009814 · doc4.xml · derivative · entry 10 DALY RICHARD J · CIK 0001198860 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,780 Underlying: Common Stock · 36,780 shares Expires 2029-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 26, 2022 Filed Aug 26, 2022 19:39 UTC |
DALY RICHARD JDirector · Executive Chairman
|
SaleCommon Stock | 1,985 | $176.34 | $350,034.90 |
DisclosureSEC source: 0001225208-22-009814 · doc4.xml · nonDerivative · entry 5 DALY RICHARD J · CIK 0001198860 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · by The KLD 2014 Trust Disclosed balance after: 0 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.33 - $176.50, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| August 26, 2022 Filed Aug 26, 2022 19:39 UTC |
DALY RICHARD JDirector · Executive Chairman
|
SaleCommon Stock | 64,300 | $175.39 | $11,277,577.00 |
DisclosureSEC source: 0001225208-22-009814 · doc4.xml · nonDerivative · entry 4 DALY RICHARD J · CIK 0001198860 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,169.9949 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.26 - $175.88, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| August 26, 2022 Filed Aug 26, 2022 19:39 UTC |
DALY RICHARD JDirector · Executive Chairman
|
SaleCommon Stock | 8,683 | $175.04 | $1,519,872.32 |
DisclosureSEC source: 0001225208-22-009814 · doc4.xml · nonDerivative · entry 3 DALY RICHARD J · CIK 0001198860 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,469.9949 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.00 - $175.53, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| August 26, 2022 Filed Aug 26, 2022 19:39 UTC |
DALY RICHARD JDirector · Executive Chairman
|
Exercise / conversionCommon Stock | 35,817 | $93.88 | $3,362,499.96 |
DisclosureSEC source: 0001225208-22-009814 · doc4.xml · nonDerivative · entry 2 DALY RICHARD J · CIK 0001198860 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,152.9949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 26, 2022 Filed Aug 26, 2022 19:39 UTC |
DALY RICHARD JDirector · Executive Chairman
|
Exercise / conversionCommon Stock | 36,780 | $98.31 | $3,615,841.80 |
DisclosureSEC source: 0001225208-22-009814 · doc4.xml · nonDerivative · entry 1 DALY RICHARD J · CIK 0001198860 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,335.9949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2022 Filed Aug 19, 2022 20:16 UTC |
PERRY CHRISTOPHER JOHNPresident
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,179 | $0.00 Strike: $93.88 | $0.00 |
DisclosureSEC source: 0001225208-22-009684 · doc4.xml · derivative · entry 3 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,179 shares Expires 2028-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2022 Filed Aug 19, 2022 20:16 UTC |
PERRY CHRISTOPHER JOHNPresident
|
SaleCommon Stock | 3,702 | $176.28 | $652,576.71 |
DisclosureSEC source: 0001225208-22-009684 · doc4.xml · nonDerivative · entry 2 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,809.528 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.18 - $176.38, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| August 19, 2022 Filed Aug 19, 2022 20:16 UTC |
PERRY CHRISTOPHER JOHNPresident
|
Exercise / conversionCommon Stock | 4,179 | $93.88 | $392,324.52 |
DisclosureSEC source: 0001225208-22-009684 · doc4.xml · nonDerivative · entry 1 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,511.528 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2022 Filed Aug 17, 2022 13:55 UTC |
Matlin LauraVP, Deputy GC and CGO
|
SaleCommon Stock | 2,067 | $177.81 | $367,539.68 |
DisclosureSEC source: 0001225208-22-009614 · doc4.xml · nonDerivative · entry 1 Matlin Laura · CIK 0001658944 · VP, Deputy GC and CGO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,617.696 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.810 - $177.875, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| August 17, 2022 Filed Aug 17, 2022 18:51 UTC |
KALENKA ROBERT FCorporate Vice President
|
GiftCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-009618 · doc4.xml · nonDerivative · entry 1 KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,802.4097 F1 · price: The reported disposition represents a bona fide charitable gift made by the reporting person. Read SEC document |
| August 16, 2022 Filed Aug 17, 2022 17:56 UTC |
Gumbs Keir DCVP and Chief Legal Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 12,209 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-009615 · doc4.xml · derivative · entry 3 Gumbs Keir D · CIK 0001876435 · CVP and Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,848 Underlying: Common Stock · 12,209 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represented one share of Broadridge common stock and on August 16, 2022 12,209 Restricted Stock Units vested and converted into an equal number of shares of common stock. F1 · price: Each Restricted Stock Unit represented one share of Broadridge common stock and on August 16, 2022 12,209 Restricted Stock Units vested and converted into an equal number of shares of common stock. F1 · derivative.exercise_date: Each Restricted Stock Unit represented one share of Broadridge common stock and on August 16, 2022 12,209 Restricted Stock Units vested and converted into an equal number of shares of common stock. F1 · derivative.expiration_date: Each Restricted Stock Unit represented one share of Broadridge common stock and on August 16, 2022 12,209 Restricted Stock Units vested and converted into an equal number of shares of common stock. Read SEC document |
| August 16, 2022 Filed Aug 17, 2022 17:56 UTC |
Gumbs Keir DCVP and Chief Legal Officer
|
Tax withholdingCommon Stock | 5,867 | $177.32 | $1,040,336.44 |
DisclosureSEC source: 0001225208-22-009615 · doc4.xml · nonDerivative · entry 2 Gumbs Keir D · CIK 0001876435 · CVP and Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,552.22 Read SEC document |
| August 16, 2022 Filed Aug 17, 2022 17:56 UTC |
Gumbs Keir DCVP and Chief Legal Officer
|
Exercise / conversionCommon Stock | 12,209 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-009615 · doc4.xml · nonDerivative · entry 1 Gumbs Keir D · CIK 0001876435 · CVP and Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,419.22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represented one share of Broadridge common stock and on August 16, 2022 12,209 Restricted Stock Units vested and converted into an equal number of shares of common stock. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 20:27 UTC |
Carey Thomas PCorporate VP
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,399 | $0.00 Strike: $67.32 | $0.00 |
DisclosureSEC source: 0001225208-22-009604 · doc4.xml · derivative · entry 10 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,399 shares Expires 2027-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 20:27 UTC |
Carey Thomas PCorporate VP
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,222 | $0.00 Strike: $50.95 | $0.00 |
DisclosureSEC source: 0001225208-22-009604 · doc4.xml · derivative · entry 9 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,222 shares Expires 2025-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 20:27 UTC |
Carey Thomas PCorporate VP
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,696 | $0.00 Strike: $51.95 | $0.00 |
DisclosureSEC source: 0001225208-22-009604 · doc4.xml · derivative · entry 8 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,696 shares Expires 2026-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 20:27 UTC |
Carey Thomas PCorporate VP
|
SaleCommon Stock | 5,000 | $179.16 | $895,776.50 |
DisclosureSEC source: 0001225208-22-009604 · doc4.xml · nonDerivative · entry 7 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,902 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.86 - $179.75, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 20:27 UTC |
Carey Thomas PCorporate VP
|
SaleCommon Stock | 4,502 | $179.16 | $806,557.16 |
DisclosureSEC source: 0001225208-22-009604 · doc4.xml · nonDerivative · entry 6 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,902 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.86 - $179.75, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 20:27 UTC |
Carey Thomas PCorporate VP
|
SaleCommon Stock | 3,631 | $179.16 | $650,512.89 |
DisclosureSEC source: 0001225208-22-009604 · doc4.xml · nonDerivative · entry 5 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,404 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.86 - $179.75, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 20:27 UTC |
Carey Thomas PCorporate VP
|
SaleCommon Stock | 3,570 | $179.16 | $639,584.42 |
DisclosureSEC source: 0001225208-22-009604 · doc4.xml · nonDerivative · entry 4 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,035 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.86 - $179.75, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.